Sponsor pipeline

NRG Oncology clinical trial pipeline

Get alerts when NRG Oncology's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.

Notable

Individualized Treatment · Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Primary completion pushed from Dec 1, 2026 to Jan 1, 2029

Also in this update: Study completion pushed from Dec 1, 2031 to Jan 1, 2034

NRG OncologyPhase 2/3 NCT02135042 Registry history of NCT02135042 on ClinicalTrials.gov (opens the registry)

Oct 13, 2026

Show 4 trials with minor changes only

Minor

Observation or Radiation Therapy · Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Enrollment closed, study ongoing

NRG OncologyPhase 3 NCT03180268 Registry history of NCT03180268 on ClinicalTrials.gov (opens the registry)

Oct 2, 2026
Minor

Radiation Therapy With or Without Apalutamide · Recurrent Prostate Cancer, the BALANCE Trial

Study completion pushed from Oct 27, 2026 to Mar 10, 2030

NRG OncologyPhase 2 NCT03371719 Registry history of NCT03371719 on ClinicalTrials.gov (opens the registry)

Oct 1, 2026
Minor

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide · Newly Diagnosed Glioblastoma

Study completion pushed from Dec 31, 2026 to Jul 7, 2030

NRG OncologyPhase 2 NCT02179086 Registry history of NCT02179086 on ClinicalTrials.gov (opens the registry)

Oct 1, 2026
Minor

Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation · Advanced Esophageal Cancer and Are Not Candidates for Surgery

Study completion moved earlier from Oct 6, 2030 to Oct 6, 2029

NRG OncologyPhase 1 NCT04391049 Registry history of NCT04391049 on ClinicalTrials.gov (opens the registry)

Oct 1, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First posted	Trial	Phase	Status
2026-09-23	NCT07835789 Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer	Phase 2	Not Yet Recruiting

Active trials by phase

Phase 1		2
Phase 2		9
Phase 2/3		5
Phase 3		30

Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 21

Breast Cancer (9) · Prostate Cancer (8) · Lung Cancer (6) · Head & Neck Cancer (5) · Non-Small Cell Lung Cancer (NSCLC) (5) · Glioma (4) · Colorectal Cancer (3) · Glioblastoma (3) · Ovarian Cancer (3) · Esophageal Cancer (2)

Get alerts when NRG Oncology's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free